Abinopharm, Inc. proudly participated in the 2026 NUS Unlock Healthy Longevity Conference, held on February 26–27, 2026 at the Shaw Foundation Alumni House, National University of Singapore (NUS). Organized by the NUS Academy for Healthy Longevity, the conference brought together leading scientists, clinicians, regulators, and industry innovators to discuss evidence-based approaches for extending human healthspan and advancing geromedicine.

Representing Abinopharm, CEO Lin Yi delivered a presentation titled “Ergothioneine industrial manufacturing process,” highlighting the company’s expertise in pharmaceutical-grade healthy longevity ingredients and advanced fermentation technologies. The presentation was featured in a dedicated ergothioneine session alongside internationally recognized researchers including Barry Halliwell and Robert Beelman.

Lin Yi’s presentation is available here:
Watch the Presentation on YouTube

The conference focused on emerging interventions for healthy aging, including NAD+ precursors, mitochondrial enhancers, bioactive compounds, and gerotherapeutics. Discussions highlighted the growing scientific interest in ergothioneine and its potential role in supporting healthy aging, cellular resilience, and longevity science.

As a science-driven healthy longevity company headquartered in Shelton, Connecticut, Abinopharm, Inc. continues to support the global longevity community through innovative ingredients including AbinoNutra® NMN and Dr.Ergo® L-Ergothioneine. The company remains committed to advancing research, quality manufacturing, and global collaboration in healthy aging and longevity science.